APA
Dorman S. E., Nahid P., Kurbatova E. V., Goldberg S. V., Bozeman L., Burman W. J., Chang K., Chen M., Cotton M., Dooley K. E., Engle M., Feng P., Fletcher C. V., Ha P., Heilig C. M., Johnson J. L., Lessem E., Metchock B., Miro J. M., Nhung N. V., Pettit A. C., Phillips P. P. J., Podany A. T., Purfield A. E., Robergeau K., Samaneka W., Scott N. A., Sizemore E., Vernon A., Weiner M., Swindells S. & Chaisson R. E. (20210519). High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. : Contemporary clinical trials.
Chicago
Dorman Susan E, Nahid Payam, Kurbatova Ekaterina V, Goldberg Stefan V, Bozeman Lorna, Burman William J, Chang Kwok-Chiu, Chen Michael, Cotton Mark, Dooley Kelly E, Engle Melissa, Feng Pei-Jean, Fletcher Courtney V, Ha Phan, Heilig Charles M, Johnson John L, Lessem Erica, Metchock Beverly, Miro Jose M, Nhung Nguyen Viet, Pettit April C, Phillips Patrick P J, Podany Anthony T, Purfield Anne E, Robergeau Kathleen, Samaneka Wadzanai, Scott Nigel A, Sizemore Erin, Vernon Andrew, Weiner Marc, Swindells Susan and Chaisson Richard E. 20210519. High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. : Contemporary clinical trials.
Harvard
Dorman S. E., Nahid P., Kurbatova E. V., Goldberg S. V., Bozeman L., Burman W. J., Chang K., Chen M., Cotton M., Dooley K. E., Engle M., Feng P., Fletcher C. V., Ha P., Heilig C. M., Johnson J. L., Lessem E., Metchock B., Miro J. M., Nhung N. V., Pettit A. C., Phillips P. P. J., Podany A. T., Purfield A. E., Robergeau K., Samaneka W., Scott N. A., Sizemore E., Vernon A., Weiner M., Swindells S. and Chaisson R. E. (20210519). High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. : Contemporary clinical trials.
MLA
Dorman Susan E, Nahid Payam, Kurbatova Ekaterina V, Goldberg Stefan V, Bozeman Lorna, Burman William J, Chang Kwok-Chiu, Chen Michael, Cotton Mark, Dooley Kelly E, Engle Melissa, Feng Pei-Jean, Fletcher Courtney V, Ha Phan, Heilig Charles M, Johnson John L, Lessem Erica, Metchock Beverly, Miro Jose M, Nhung Nguyen Viet, Pettit April C, Phillips Patrick P J, Podany Anthony T, Purfield Anne E, Robergeau Kathleen, Samaneka Wadzanai, Scott Nigel A, Sizemore Erin, Vernon Andrew, Weiner Marc, Swindells Susan and Chaisson Richard E. High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial. : Contemporary clinical trials. 20210519.